secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001711279-23-000069
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech Chief Commercial Officer Andrew Orth resigns
------------------------------------------------------------

- Andrew Orth resigned as Chief Commercial Officer, effective August 2, 2023.
- No successor has been announced; reason for departure not disclosed.
- The resignation is reported under Item 5.02 of Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/0001711279-23-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000171127923000069/krys-20230802.htm
  HTML page:      https://secwatch.observer/filing/0001711279-23-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer